心血管疾病中的CaMK II,特别是CaMK II-δ:朋友或敌人
Yu-Qing Tan1, Wang Zhang2, Zi-Cong Xie1
1Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Drug design, development and therapy
|August 12, 2024
概括
在心血管疾病 (CVD) 中,/卡尔莫杜林依赖激酶II (CaMK II) 是至关重要的. 准CaMK II异型可能为复杂的心脏病提供新的治疗策略.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 是一个重大的社会和经济挑战,经常影响年轻人群.
- 心血管疾病的潜在生理和病理机制是复杂的,并未完全理解.
- /卡尔莫杜林依赖激酶II (CaMK II) 是一种关键的蛋白激酶,涉及各种生物功能和病理过程.
研究的目的:
- 分析CaMK II的结构特征和分布.
- 阐明CaMK II在心血管健康和疾病中的作用机制.
- 探索CaMK II与各种心血管疾病之间的多方面的关系.
主要方法:
- 文献综述和对CAMKII现有研究的分析.
- 检查CaMK II在离子通道功能中的作用.
- 调查CaMK II在缺血-再输液损伤,心律失常,心肌缩,心脏毒性,高血压和扩张性心肌病的参与.
主要成果:
- 在许多心血管疾病的发病过程中,CaMK II起着核心作用.
- 蛋白激酶影响各种心血管过程,包括电信号和结构重塑.
- 不同的CaMK II异型表现出不同的调节机制.
结论:
- 在心血管疾病的发展和进展中,CaMK II 是一个关键的调解者.
- 了解CaMK II的特定作用和同型调节对于治疗开发至关重要.
- 未来的研究应该专注于针对性抑制剂和CaMK II的新化合物,以建立对心血管疾病的新治疗方向.
相关概念视频
01:16Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
474
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
474
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
481
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
481
01:25cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:31Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K